Tg(LCR-HBG2,-HBG1)1352Hhb
Transgene Detail
|
|
| Symbol: |
Tg(LCR-HBG2,-HBG1)1352Hhb |
| Name: |
transgene insertion 1352, Henny Billett |
| MGI ID: |
MGI:6277094 |
| Synonyms: |
LCR Ggamma Agamma psi beta |
| Transgene: |
Tg(LCR-HBG2,-HBG1)1352Hhb Location: unknown
|
| Alliance: |
Tg(LCR-HBG2,-HBG1)1352Hhb page
|
|
| Strain of Origin: |
(C57BL/6 x SJL)F2
|
|
| Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The human beta globin cluster is modified such that the locus control region (LCR) consisting of 4 DNAse I hypersensitive site (HS4-1) is inserted upstream of HBG2, HBG1, and the HBBP1 pseudogene. Founder line 1352 was established. Expression of the HBG2 gene is 3-7 fold higher than the HBG1 gene in embryonic and fetal erythroid cells.
(J:39123)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:39123 Arcasoy MO, et al., High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin. Mol Cell Biol. 1997 Apr;17(4):2076-89 |
| All: |
2 reference(s) |
|